International Clinical Trial: Deprescribing Beta-Blockers in Elders With Heart Failure With Preserved Ejection Fraction (DEPRESCRIBE-HFpEF)

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07298993) titled 'Deprescribing Beta-Blockers in Elders With Heart Failure With Preserved Ejection Fraction (DEPRESCRIBE-HFpEF)' on Dec. 19, 2025.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Health Services Research. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Weill Medical College of Cornell University

Condition: Heart Failure HFpEF HFpEF - Heart Failure With Preserved Ejection Fraction

Intervention: Drug: Placebo (matching)

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enr...